Atlas Trials

GWT-TUD GmbH

39 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch GWT-TUD GmbH

RecordFirmDate
Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From Lower-risk Myelodysplastic Syndrome. (NCT05181592)GWT-TUD GmbH2021-10-27
Polatuzumab Vedotin Plus Rituximab, Ifosfamide, Carboplatin and Etoposide (Pola-R-ICE) Versus R-ICE Alone in Second Line Treatment of Diffuse Large B-cell Lymphoma (DLBCL) (NCT04833114)GWT-TUD GmbH2021-04-30
Emicizumab in Acquired Hemophilia A (NCT04188639)GWT-TUD GmbH2021-03-23
Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer (NCT04257448)GWT-TUD GmbH2020-05-25
Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Oligoblastic AML (NCT04061239)GWT-TUD GmbH2019-08-19
ASTRAL- a Clinical Study to Assess the Efficacy and Toxicity of High-dose Chemotherapy (NCT04121507)GWT-TUD GmbH2019-06-24
Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes (NCT03824080)GWT-TUD GmbH2018-12-20
Study in Patients With Chronic Leukemia (NCT03807479)GWT-TUD GmbH2018-12-11
Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib (NCT03735758)GWT-TUD GmbH2018-11-02
Pomalidomide, Ixazomib, and Dexamethasone With or Without Intensification by Cyclophosphamide in Relapsed or Refractory Multiple Myeloma (NCT03731832)GWT-TUD GmbH2018-09-20
Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis (NCT03568136)GWT-TUD GmbH2018-09-18
EXPLorative Data Collection for Patient chAracterIzation, treatmeNt Pathways and Outcomes of IRON Preparations (NCT03382275)GWT-TUD GmbH2018-01-16

Track GWT-TUD GmbH automatically

Every clearance here is in the API, with alerts when new ones post.